Last updated: November 12, 2024
Sponsor: San Luigi Gonzaga Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT06688383
ALRIGHT01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients from all participating centers older than 18 years, males or females, withthe diagnosis of primary right colon cancer including the cecum, ascendent, liverflexure, and proximal third of the transverse colon, in both emergency and electivesettings, with the indication of RH, referred as to the resection of a portion ofthe distal ileum, cecum, ascending colon, and proximal to the mid-transverse colon,with intraperitoneal or extraperitoneal primary handsewn or mechanical ileocolicanastomosis by minimally invasive(robotic or laparoscopic) or open approach.
Exclusion
Exclusion Criteria:
-Long steroid treatment for any cause.
Right colon resection for benign disease.
History of supra-mesocolic space radiotherapy.
Inflammatory bowel disease (Crohn's disease and ulcerative colitis). No healthyvolunteers are accepted.
Study Design
Total Participants: 1839
Study Start date:
January 01, 2021
Estimated Completion Date:
June 30, 2026
Connect with a study center
San Luigi Gonzaga
Orbassano, Piedmont 10043
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.